Company
Headquarters: Zofingen, Switzerland
Employees: 3,338
CHF3.14 Billion
CHF as of July 1, 2023
US$3.51 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$78.54 B |
![]() |
$70.69 B |
![]() |
$46.59 B |
![]() |
$37.99 B |
![]() |
$17.26 B |
Company | Market Cap (USD) |
---|---|
![]() |
$428.70 B |
![]() |
$417.05 B |
![]() |
$412.24 B |
![]() |
$329.83 B |
![]() |
$275.82 B |
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling liquid dosage forms. It offers contract development and manufacturing services, including process and chemical development, analytical development, pilot manufacturing and scale up, and commercial manufacturing. The company also provides APIs and controlled substances focusing on anesthetics, pain/addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Siegfried Holding AG has the following listings and related stock indices.
Stock: SIX: SFZN